2,6-dihydroxypyridine has been researched along with fluorouracil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kühnel, A; Podschun, B; Stopper, H | 1 |
Aiba, K; Fukushima, M; Murakami, Y; Nomura, H; Shirasaka, T | 1 |
2 other study(ies) available for 2,6-dihydroxypyridine and fluorouracil
Article | Year |
---|---|
Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction.
Topics: Animals; Binding Sites; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Kinetics; L Cells; Liver; Mice; Micronuclei, Chromosome-Defective; Oxidoreductases; Pyridines; Swine; Uracil | 1994 |
[Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
Topics: Animals; Colorectal Neoplasms; Enzyme Inhibitors; Fluorouracil; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms; Orotate Phosphoribosyltransferase; Oxonic Acid; Pentosyltransferases; Phosphorylation; Pyridines; Stomach Neoplasms; Tumor Cells, Cultured | 1996 |